Vitamin D Treatment in Patients With Chronic Hepatitis C
NCT00804752 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2008-12-09
Summary
We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.
Conditions
- Chronic Hepatitis C
Interventions
- DRUG
-
Adding vitamin D
Adding 1000IU/Vitamin D daily
- DRUG
-
Addition of 1000IU/day Vitamin D
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Israel
Study Locations
More Related Trials
-
Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.
NCT00408304 ·Status: UNKNOWN ·Phase: PHASE2
-
Hepatitis C Treatment and Atherosclerosis
NCT00659256 ·Status: COMPLETED
-
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
NCT00819026 ·Status: COMPLETED
-
Nutritional Support During Antiviral Therapy for Hepatitis C
NCT00841243 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
Reducing Depressive Symptoms During HCV Therapy: A Randomized Study
NCT00495768 ·Status: UNKNOWN ·Phase: NA
-
Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy
NCT00747539 ·Status: COMPLETED
-
HCV Treatment Initiation During Acute Psychiatric Admission
NCT04625322 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Antiviral Therapy With Pegylated Interferon-alpha on Auditory Disability
NCT01265693 ·Status: COMPLETED
-
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
NCT00674492 ·Status: COMPLETED
-
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
NCT03364725 ·Status: UNKNOWN ·Phase: PHASE4
-
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
NCT03170076 ·Status: UNKNOWN
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
NCT02294136 ·Status: COMPLETED ·Phase: NA
-
Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C
NCT00948220 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users
NCT00194480 ·Status: COMPLETED ·Phase: PHASE4
-
Directly Observed Hepatitis C Treatment in Methadone Clinics
NCT01442311 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy
NCT01045278 ·Status: COMPLETED ·Phase: PHASE4
-
Relinking Diagnosed But Untreated HCV Patients Back Into Care.
NCT05975216 ·Status: COMPLETED
-
Adherence in Patients Receiving PegIntron/Rebetol for Hepatitis C in Conjunction With a Psychotherapy Support Program (Study P04252)
NCT00723892 ·Status: COMPLETED
-
Risk of HCC in Cirrhotic Patients Post DAAs Ttt
NCT03414554 ·Status: UNKNOWN
-
Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.
NCT01909557 ·Status: COMPLETED ·Phase: PHASE3
-
Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy
NCT01120795 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C
NCT01465919 ·Status: TERMINATED ·Phase: PHASE4